QMatter reduces the size of complex simulation problems in life and materials science, extending the capabilities of current quantum systems while also accelerating classical algorithms.
Quantum technology startup QMatter has raised $1.2M in pre-seed funding, led by 55 North, the world’s largest pure-play quantum fund, with participation from XTX Ventures, Bellstate Oy and the Conception X Angel Syndicate. The company will use the capital to further develop and scale its quantum compression platform.
Simulating quantum mechanics is extremely computationally demanding, and current computers, both classical and quantum, cannot handle the most complex challenges in drug discovery and materials science.
QMatter’s current focus is the life sciences market, working with pharmaceutical and biotechnology companies to accelerate R&D by enabling better simulation data and ultimately improving research outcomes. In parallel, the company is generating high‑quality, physics‑informed data libraries, creating new opportunities for machine learning companies to train next‑generation AI models using previously unavailable, problem‑specific data.
Quantum computers, which process information using quantum mechanical principles, are theoretically well-suited to these simulations. But despite rapid hardware progress, a fundamental limitation remains: today’s systems cannot reliably scale to industrially relevant problem sizes. Quantum devices have limited qubit counts, while noise and instability reduce the number of usable qubits further. As a result, the most commercially valuable simulations remain out of reach.
QMatter’s quantum compression technology applies principles from quantum mechanics to reduce the size of a problem before it is run on a quantum or classical system. The approach is designed to extend what current, near-term and future quantum computers can handle, while also accelerating classical algorithms at every scale, from consumer hardware to large supercomputers. This dual approach positions QMatter at the forefront of algorithms design, where previously intractable problems are reduced to a size where solutions become possible today.
“QMatter compresses complex quantum problems to their essential core, ensuring solutions remain both accurate and useful. By doing so, we unlock greater performance from today’s quantum hardware while broadening the problem landscape for future error-corrected machines.”
– Dr. Alexis Ralli, Co-founder & CEO, QMatter
“Quantum computing promises to be transformational for the hardest problems we face, but the full value remains unrealized due to real-world limitations that constrain the size of problems we can address today. This investment will support the continued development of our quantum compression platform.”
– Dr. Tim Weaving, Co-founder & CTO, QMatter
About Q Matter
QMatter was founded in 2024 by Dr. Alexis Ralli and Dr. Timothy Weaving, who obtained their PhDs in quantum computing and molecular modelling from University College London, alongside Prof. Peter Coveney (University College London) and Prof. Peter Love (Tufts University). The founding team have backgrounds in quantum computing and high-performance computing, with a focus on life science applications.
“The first commercially valuable applications of quantum computing devices will likely be in chemistry and pharmaceuticals. QMatter’s compression approach accelerates the timelines and brings these applications closer to the market.”
– Helmut Katzgraber, CSO & General Partner, 55 North
About 55 North
55 North is the world’s largest dedicated quantum technology venture capital fund, backing companies that reshape industry, accelerate discovery, and drive global progress. Headquartered in Copenhagen, Denmark, the fund invests stage-agnostically from Seed to Series B across the full quantum stack—quantum computing, sensing, and communications—targeting enabling technologies, full-stack hardware solutions, and breakthrough software applications.
Led by a team combining deep technical expertise with proven venture capital track records, 55 North partners with world-class scientists, entrepreneurs, and institutional investors to advance breakthrough quantum solutions. 55 North invests globally while building Europe’s quantum innovation ecosystem. 55 North delivers impatient, long-term capital to companies solving real-world problems, positioning quantum technologies for commercial deployment and economic impact.
Media contact: hello at qmatter.xyz